Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2006
05/17/2006CN1772008A Process of preparing ginkgo-dipyridamole for injection and its quality control method
05/17/2006CN1772004A Fermented aweto hypha powder
05/17/2006CN1771992A Brain extract and its prepn and use
05/17/2006CN1771991A Pile treating injection
05/17/2006CN1771988A Two-leaf composition for treating cardiac and cerebral vascular diseases
05/17/2006CN1771981A Pile ointment
05/17/2006CN1771978A Notoginseng triol-saponin composition and its prepn and use
05/17/2006CN1771965A Diltiazem hydrochloride and its prepn
05/17/2006CN1771964A Compound captopril dripping pill and its prepn
05/17/2006CN1771950A Freeze dried nimodipine composition and its prepn
05/17/2006CN1771949A Soft nimodipine capsule and its prepn
05/17/2006CN1771948A Felodipine dripping pill and its prepn
05/17/2006CN1771947A Nitrendipine dripping pill and its prepn
05/17/2006CN1771944A Application of high-solubility berberine in preparing medicine
05/17/2006CN1771934A Medicine composite containing red clover prime and prunetin and its medicinal application
05/17/2006CN1771923A Propafenone hydrochloride dripping pill and its prepn
05/17/2006CN1771908A Dihydroergotoxine methanesulfonate transfused-fluid and its prepn
05/17/2006CN1256420C Health care wine prepared from rhododendron and its preparation
05/17/2006CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists
05/17/2006CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
05/17/2006CN1256324C Pyrrolidine derivatives as factor Xa inhibitors
05/17/2006CN1256139C Chinese medicinal preparation for lowering viscosity and preventing embolism
05/17/2006CN1256138C Medicine for treating apoplexy and its preparing process
05/17/2006CN1256135C Medicine for treating cardiovascular and cerebrovascular disease and its preparing process
05/17/2006CN1256131C Chinese traditional medicine preparation Qimaishen for treating viral myocarditis and its manufacturing method
05/17/2006CN1256129C Acesodyne muscle regenerating paste for hemorrhoids
05/17/2006CN1256114C Chinese patent medicine for treating angiitis
05/17/2006CN1256112C Chinese traditional medicine preparation for treating cardiac and cerebral vascular diseases and its preparation process
05/17/2006CN1256107C Ginkgo leaf extraction injection for treating ischemic cerebral apoplexia and its preparation method
05/17/2006CN1256106C Medicinally health-care powder made of ganoderma and lentinan
05/17/2006CN1256104C Mastic for treating haemorrhoids
05/17/2006CN1256098C Process for preparing livestock animal brain fat composite medicine
05/17/2006CN1256097C Yak-blood deproteined extract and its extraction method and use thereof
05/17/2006CN1256086C Use of 5-hydroxymethyl furfural in preparation of drug for nerve system
05/16/2006US7045658 prophylaxis and treatment of respiratory diseases; phenethanolamine derivatives
05/16/2006US7045636 MCH antagonists for the treatment of obesity
05/16/2006US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
05/16/2006US7045544 Myocardium; angina pectoris
05/16/2006US7045541 Compounds for the treatment of metabolic disorders
05/16/2006US7045540 Selective estrogen receptor modulators
05/16/2006US7045539 Therapeutic benzoxazole compounds
05/16/2006US7045534 Methods of reducing angiogenesis
05/16/2006US7045529 Imidazopyrimidinyl and imidazopyri dinyl derivatives
05/16/2006US7045528 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
05/16/2006US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them
05/16/2006US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field
05/16/2006US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
05/16/2006US7045520 Opioid receptor active compounds
05/16/2006US7045514 Therapeutic heterocyclic compounds
05/16/2006US7045511 Fosinopril formulation
05/16/2006US7045509 Proteins and nucleic acids encoding same
05/16/2006US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
05/16/2006US7045501 Method of treating chronic cardiac disease
05/16/2006US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive
05/16/2006US7045353 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
05/16/2006US7045329 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/16/2006US7045309 9-substituted adenine derivatives as prodrug regulators of cell and tissue function
05/16/2006US7045302 Expressed ligand-vascular intercellular signaling molecule
05/16/2006US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ
05/16/2006US7045152 Pulmonary disorders in which the S-nitrosoglutathione(GSNO) pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung an agent causing repletion of GSNO
05/16/2006US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells
05/16/2006US7045147 Therapy for congestive heart failure; administering by mouth
05/16/2006US7045140 Therapeutic delivery of carbon monoxide
05/16/2006CA2291650C Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
05/16/2006CA2197628C Substituted thiophenylalkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/16/2006CA2192916C Substituted chromanylsulfonyl(thio)ureas, processes for their preparation, their use in pharmaceutical preparations, and pharmaceutical preparations comprising them
05/16/2006CA2192797C Indolinone compounds for the treatment of disease
05/11/2006WO2006050509A2 Amorphous and polymorphic forms of telmisartan sodium
05/11/2006WO2006050170A2 Medical devices containing rapamycin analogs
05/11/2006WO2006049490A1 Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima
05/11/2006WO2006049234A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same
05/11/2006WO2006048628A1 Bacterial compositions for prevention or treatment of atherosclerotic disorders
05/11/2006WO2006048315A1 Use of an amino-tetraline derivative as anti-arrhythmic agent
05/11/2006WO2006048208A1 Bilayer tablet comprising telmisartan and amlodipine
05/11/2006WO2006047949A1 The use of human urinary kallidinogenase for the manufacture of a medicine for the treatment of acute coronary syndromes
05/11/2006WO2005089731A3 Use of renin inhibitors in therapy
05/11/2006WO2005044313A3 Conjugates of angiotensin ii and an imaging moiety
05/11/2006WO2005030209A8 Pyridine derivatives and use thereof as urotensin ii antagonists
05/11/2006WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
05/11/2006US20060100446 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
05/11/2006US20060100445 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
05/11/2006US20060100278 Dosage forms and related therapies
05/11/2006US20060100269 Use of 10-aminoaliphatyl-dibenz[b,f]oxepines for the treatment of degenerative ocular disorders
05/11/2006US20060100268 Method of treating atherosclerosis or restenosis using microtube stabilizing agent
05/11/2006US20060100267 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
05/11/2006US20060100261 Furan or thiopene derivative and medicinal use thereof
05/11/2006US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
05/11/2006US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt
05/11/2006US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
05/11/2006US20060100233 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/11/2006US20060100230 Indolin phenylsulfonamide derivatives
05/11/2006US20060100227 Pyrimidine derivaties
05/11/2006US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/11/2006US20060100199 Novel condensed imidazole derivatives
05/11/2006US20060100197 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation
05/11/2006US20060100196 Substituted amines for the treatment of alzheimer's disease
05/11/2006US20060100184 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
05/11/2006US20060100175 Novel therapeutic use of low molecular weight heparins
05/11/2006US20060100159 Preventing desensitization of receptors
05/11/2006US20060100137 Monodispersed insulin polypeptide-oligomer conjugates; for administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes